Preservé Breast Augmentation in Turkey: Tissue-Preserving Enhancement

Preservé breast augmentation in Turkey is a contemporary approach for selected patients who want a proportionate increase in breast volume while prioritising the preservation of natural tissues. Preservé™ was introduced by Establishment Labs as a tissue-preserving platform that combines dedicated minimally invasive instruments with Motiva Ergonomix2® implants. It should not be presented as a completely different operation without risks, nor as the right answer for every patient. Its value lies in careful patient selection, measured enhancement and a surgical plan intended to minimise unnecessary disruption of the breast’s supporting anatomy.

Prof. Dr. Ufuk Bilkay evaluates the breast envelope, existing volume, skin quality, nipple position, chest-wall dimensions and the patient’s desired result together. For international patients considering treatment in Izmir, consultation also includes implant information, long-term follow-up, travel planning and a realistic comparison between Preservé and conventional breast augmentation. Availability and suitability must be confirmed individually because the technique depends on anatomy, implant choice, surgeon training and local device availability.

What Is Preservé Breast Augmentation in Turkey?

Preservé is a branded breast-tissue-preservation approach developed for primary aesthetic breast augmentation. According to the manufacturer, the system uses controlled tissue expansion and dedicated instruments to create an implant space while preserving important structural tissues as far as the planned operation allows. The implant is generally positioned without cutting the pectoral muscle. A smaller access incision may be possible because compatible Ergonomix2 implants are designed for controlled insertion, but incision length still depends on implant dimensions, tissue characteristics and safe surgical access.

The word “preservation” requires careful interpretation. Every operation creates an incision and involves tissue handling. Preservé aims to reduce avoidable tissue trauma; it cannot promise zero trauma, zero pain, invisible scars or an immediate return to unrestricted activity. It also remains an implant-based operation, so the established short- and long-term considerations of breast implants still apply.

Why Patients Are Interested in a Tissue-Preserving Approach

Many patients today are not seeking the largest possible augmentation. They want a refined increase that fits their shoulders, ribcage, waist and existing breast footprint. They may also wish to avoid an obviously augmented upper pole. Preservé is particularly relevant to this “proportion first” philosophy because planning begins with the natural tissue envelope rather than an arbitrary cup-size request.

• A measured increase in breast volume and projection
• Natural movement and a soft transition from chest to breast
• Preservation of the pectoral muscle
• Controlled pocket creation with dedicated instrumentation
• A potentially smaller incision in suitable anatomy
• Less disruption of supporting tissues than some conventional dissections
• A recovery plan centred on early, safe mobility

These are planning objectives, not guarantees. Final softness, movement, cleavage and scar quality vary with implant volume, breast width, skin thickness, healing and the patient’s starting anatomy.

Preservé vs Traditional Breast Augmentation

Traditional augmentation is not one single technique. An implant may be placed above the muscle, below the muscle, in a dual plane or beneath the fascia. Each option has legitimate indications. Conventional surgery may be more appropriate when greater pocket control is required, when there is significant asymmetry, when a lift is necessary, or when previous surgery has altered the tissues.

Preservé uses a standardised, tissue-preserving concept and dedicated tools, generally with an above-muscle relationship. The practical difference is therefore not simply “small scar versus large scar.” It concerns how the pocket is formed, how much tissue is released, which implant is used and whether the patient’s breast envelope can safely support the intended volume. A thoughtful consultation should compare both pathways rather than assuming that the newest pathway is automatically superior.

Who May Be a Good Candidate?

A suitable candidate is generally a healthy adult with realistic expectations, adequate tissue coverage and a desire for a moderate, anatomy-compatible enhancement. Patients should be at a stable weight, not pregnant or breastfeeding, and willing to follow implant surveillance recommendations. Smoking and nicotine use increase wound-healing risks and must be discussed honestly.

Preservé may be especially appealing to patients with relatively good skin tone, a stable breast position and limited sagging. It may not be the best standalone choice when the nipple sits significantly below the breast crease, the skin envelope is very loose, a substantial size increase is requested, the breasts require extensive reshaping, or a complex revision is needed. In those situations, a breast lift, conventional augmentation or revision plan may offer better control.

Consultation and Implant Planning

Implant selection should never be based on a celebrity photograph or cup size alone. Breast width, tissue thickness, nipple-to-fold distance, skin elasticity and chest-wall asymmetry determine which dimensions are appropriate. During consultation, Prof. Dr. Bilkay assesses these measurements and discusses the difference between subtle restoration, visible enhancement and disproportionate enlargement.

Patients should receive the manufacturer’s implant information and understand the device surface, gel, profile, dimensions and warranty conditions. They should also know that implants are not lifetime devices. Future imaging, revision, replacement or removal may become necessary. The consultation is the correct time to discuss pregnancy plans, breastfeeding, mammography, previous breast disease and family history.

How the Preservé Procedure Is Performed

The operation begins with carefully planned markings and anaesthesia selected for patient safety and the intended procedure. Through a discreet incision, dedicated instruments are used to prepare and expand the planned implant pocket in a controlled manner. Implant insertion follows strict sterile technique and minimal handling principles. The incision is then closed in layers and supported with dressings or a surgical bra.

Exact operative details vary, and not every marketing description applies to every patient. Whether local anaesthesia, sedation or general anaesthesia is appropriate must be decided by the surgeon and anaesthesia team. The priority is a safe, reproducible procedure—not meeting a predetermined promise about anaesthesia or operating time.

Recovery and Returning Home

Patients are encouraged to walk early and follow an individualised movement plan. Tightness, swelling, bruising and temporary changes in sensation can occur even with a tissue-preserving technique. Many patients can perform light daily activities relatively early, but this does not mean the internal tissues are fully healed. Heavy lifting, intense upper-body exercise, swimming and pressure on the breasts remain restricted until approved.

International patients should not schedule surgery immediately before a flight. The recommended stay in Izmir depends on the examination, anaesthesia plan and postoperative checks. Before departure, the clinic reviews wound care, garment use, medication, activity, warning signs and the remote follow-up schedule. A responsible plan also identifies where the patient can obtain local medical assessment after returning home if needed.

Risks, Limitations and Long-Term Implant Safety

Preservé does not eliminate the established risks of implant surgery. Possible complications include bleeding, infection, seroma, delayed healing, scarring, altered nipple or breast sensation, asymmetry, implant visibility or palpability, rippling, malposition, capsular contracture, rupture and the need for revision surgery. Anaesthesia and venous-thromboembolism risks are also considered according to the patient’s health and travel plan.

The FDA explains that breast implants are not lifetime devices and that the chance of complications increases over time. Patients must also receive balanced information about systemic symptoms sometimes called breast implant illness, BIA-ALCL, and rare cancers reported in the capsule around implants. BIA-ALCL has been reported more frequently with textured surfaces than smooth surfaces, but all implant patients should know which symptoms require assessment, including persistent late swelling, a mass or unexplained pain.

Natural Results Require Conservative Decisions

A natural-looking result is not created by the implant name alone. It comes from matching implant dimensions to the breast footprint, maintaining adequate tissue coverage, respecting the fold and accepting the limitations of the patient’s anatomy. A very large implant can stretch tissues and undermine the preservation philosophy. For this reason, Prof. Dr. Bilkay’s planning prioritises proportion and long-term tissue behaviour over a short-term size target.

Preservé Breast Augmentation for International Patients

Remote assessment can begin with health information, breast measurements where appropriate and standardised photographs, but it does not replace an in-person examination. Patients travelling to Turkey should share previous operative reports, implant cards, mammography or ultrasound findings and a complete medication list. Translation support, informed consent, postoperative access and travel timing are part of the clinical pathway—not optional tourism extras.

If you are considering Preservé breast augmentation in Turkey, the first step is to determine whether a tissue-preserving implant approach truly matches your anatomy and goals. A personalised consultation with Prof. Dr. Ufuk Bilkay in Izmir compares Preservé with conventional augmentation, breast lift and other appropriate options so that the final plan is medically responsible as well as aesthetically refined.